Stefan Rampf to take over as CFO at Rentschler on 1 May

He will be responsible for commercial management

Rentschler Biotechnologie, a German contract development and manufacturing organisation, says Stefan Rampf will become the firm's new Chief Financial Officer (CFO) on 1 May.

Rampf will be responsible for commercial management. He has around 10 years' experience as CFO with a number of firms, most recently with ABL Technik Entlackung, Leutkirch, and, until 2013, with Volvo Financial Services in Frankfurt.

You may also like

Manufacturing

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

Exceptional capabilities in guiding therapies from early stage development through to market based on more than 50 years of biotech experience
Manufacturing

Rentschler Biopharma announces major client project for new US facility

State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year
Manufacturing

Rentschler receives MHRA approval for AAV vector facility

The CDMO has received a cGMP following an MHRA visit to its UK site, now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy
Manufacturing

Rentschler awarded in CDMO Leadership Awards

The CDMO Leadership Awards Ceremony and Reception will be held in New York City on March 22, 2023
Manufacturing

Rentschler Biopharma strengthens leadership team

Dr Frank Mathias, CEO of Rentschler Biopharma said: “I am delighted to welcome Günter, Christiane, and Elke to Rentschler Biopharma”
Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Manufacturing

Rentschler Biotechnologie announces transition into EU corporation

Rentschler Biotechnologie, announced it has successfully transitioned into a European corporation (SE), Rentschler Biopharma SE, with entry into the German commercial register on 1 October, 2017
Subscribe now